BACKGROUND: The correlation between neuropathological lesions and cognition is modest. Some individuals remain cognitively intact despite the presence of significant Alzheimer's disease (AD) pathology, whereas others manifest cognitive symptoms and dementia in the same context. The aim of the present study was to examine cognitive and cerebral reserve factors associated with resilient functioning in the setting of AD pathology. METHODS: University of Pennsylvania Alzheimer's Disease Center research participants with biochemical biomarker evidence of AD pathology (cerebrospinal fluid amyloid-β1-42 <192 pg/mL) and comparable medial temporal lobe atrophy were categorized by Clinical Dementia Rating Scale-Sum of Boxes (CDR-SOB) score as AD dementia (CDR-SOB >1) or AD resilient (CDR-SOB ≤0.5). Groups were compared for a variety of demographic, clinical, and neuroimaging variables to identify factors that are associated with resilience to AD pathology. RESULTS: A univariate model identified education and intracranial volume (ICV) as significant covariates. In a multivariate model with backward selection procedure, ICV was retained as a factor most significantly associated with resilience. The interaction term between ICV and education was not significant, suggesting that larger cranial vault size is associated with resilience even in the absence of more education. CONCLUSIONS: Premorbid brain volume, as measured through ICV, provided protection against clinical manifestations of dementia despite evidence of significant accumulations of AD pathology. This finding provides support for the brain reserve hypothesis of resilience to AD.
BACKGROUND: The correlation between neuropathological lesions and cognition is modest. Some individuals remain cognitively intact despite the presence of significant Alzheimer's disease (AD) pathology, whereas others manifest cognitive symptoms and dementia in the same context. The aim of the present study was to examine cognitive and cerebral reserve factors associated with resilient functioning in the setting of AD pathology. METHODS: University of Pennsylvania Alzheimer's Disease Center research participants with biochemical biomarker evidence of AD pathology (cerebrospinal fluid amyloid-β1-42 <192 pg/mL) and comparable medial temporal lobe atrophy were categorized by Clinical Dementia Rating Scale-Sum of Boxes (CDR-SOB) score as AD dementia (CDR-SOB >1) or AD resilient (CDR-SOB ≤0.5). Groups were compared for a variety of demographic, clinical, and neuroimaging variables to identify factors that are associated with resilience to AD pathology. RESULTS: A univariate model identified education and intracranial volume (ICV) as significant covariates. In a multivariate model with backward selection procedure, ICV was retained as a factor most significantly associated with resilience. The interaction term between ICV and education was not significant, suggesting that larger cranial vault size is associated with resilience even in the absence of more education. CONCLUSIONS: Premorbid brain volume, as measured through ICV, provided protection against clinical manifestations of dementia despite evidence of significant accumulations of AD pathology. This finding provides support for the brain reserve hypothesis of resilience to AD.
Authors: Christopher M Clark; Sharon Xie; Jesse Chittams; Douglas Ewbank; Elaine Peskind; Douglas Galasko; John C Morris; Daniel W McKeel; Martin Farlow; Sharon L Weitlauf; Joseph Quinn; Jeffrey Kaye; David Knopman; Hiroyuki Arai; Rachelle S Doody; Charles DeCarli; Susan Leight; Virginia M-Y Lee; John Q Trojanowski Journal: Arch Neurol Date: 2003-12
Authors: Merle C Hoenig; Gérard N Bischof; Özgür A Onur; Juraj Kukolja; Frank Jessen; Klaus Fliessbach; Bernd Neumaier; Gereon R Fink; Elke Kalbe; Alexander Drzezga; Thilo van Eimeren Journal: Eur J Nucl Med Mol Imaging Date: 2019-06-10 Impact factor: 9.236
Authors: Ju-Hee Kang; Magdalena Korecka; Michal J Figurski; Jon B Toledo; Kaj Blennow; Henrik Zetterberg; Teresa Waligorska; Magdalena Brylska; Leona Fields; Nirali Shah; Holly Soares; Robert A Dean; Hugo Vanderstichele; Ronald C Petersen; Paul S Aisen; Andrew J Saykin; Michael W Weiner; John Q Trojanowski; Leslie M Shaw Journal: Alzheimers Dement Date: 2015-07 Impact factor: 21.566
Authors: Ganesh Chauhan; Hieab H H Adams; Joshua C Bis; Galit Weinstein; Lei Yu; Anna Maria Töglhofer; Albert Vernon Smith; Sven J van der Lee; Rebecca F Gottesman; Russell Thomson; Jing Wang; Qiong Yang; Wiro J Niessen; Oscar L Lopez; James T Becker; Thanh G Phan; Richard J Beare; Konstantinos Arfanakis; Debra Fleischman; Meike W Vernooij; Bernard Mazoyer; Helena Schmidt; Velandai Srikanth; David S Knopman; Clifford R Jack; Philippe Amouyel; Albert Hofman; Charles DeCarli; Christophe Tzourio; Cornelia M van Duijn; David A Bennett; Reinhold Schmidt; William T Longstreth; Thomas H Mosley; Myriam Fornage; Lenore J Launer; Sudha Seshadri; M Arfan Ikram; Stephanie Debette Journal: Neurobiol Aging Date: 2015-01-06 Impact factor: 4.673
Authors: Selam Negash; Robert S Wilson; Sue E Leurgans; David A Wolk; Julie A Schneider; Aron S Buchman; David A Bennett; Steven E Arnold Journal: Curr Alzheimer Res Date: 2013-10 Impact factor: 3.498
Authors: William C Kreisl; Min-Jeong Kim; Jennifer M Coughlin; Ioline D Henter; David R Owen; Robert B Innis Journal: Lancet Neurol Date: 2020-11 Impact factor: 44.182
Authors: Young Won Kim; Ismael Al-Ramahi; Amanda Koire; Stephen J Wilson; Daniel M Konecki; Samantha Mota; Shirin Soleimani; Juan Botas; Olivier Lichtarge Journal: Alzheimers Dement Date: 2020-12-07 Impact factor: 21.566